Evaluation of transitions from early hypertension to hypertensive chronic kidney disease, coronary artery disease, stroke and mortality: a Thai real-world data cohort

被引:2
|
作者
Teza, Htun [1 ]
Boonmanunt, Suparee [1 ]
Unwanatham, Nattawut [1 ]
Thadanipon, Kunlawat [1 ]
Limpijankit, Thosaphol [2 ]
Pattanaprateep, Oraluck [1 ]
Pattanateepapon, Anuchate [1 ]
McKay, Gareth J. [3 ]
Attia, John [4 ]
Thakkinstian, Ammarin [1 ]
机构
[1] Mahidol Univ, Fac Med Ramathibodi Hosp, Dept Clin Epidemiol & Biostat, Bangkok, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Cardiol, Bangkok, Albania
[3] Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, North Ireland
[4] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia
来源
关键词
cohort profile; hypertension; hypertension progression; multi-state model; real-world data; survival analysis; transition probability; HIGH BLOOD-PRESSURE; RISK-FACTORS; MYOCARDIAL-INFARCTION; PERITONEAL-DIALYSIS; ALL-CAUSE; ASSOCIATION; DYSFUNCTION; POPULATION; PREVENTION; SURVIVAL;
D O I
10.3389/fcvm.2023.1170010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveSystemic arterial hypertension (HT) is a major modifiable risk factor for cardiovascular disease (CVDs), associated with all-cause death (ACD). Understanding its progression from the early state to late complications should lead to more timely intensification of treatment. This study aimed to construct a real-world cohort profile of HT and to estimate transition probabilities from the uncomplicated state to any of these long-term complications; chronic kidney disease (CKD), coronary artery disease (CAD), stroke, and ACD.MethodsThis real-world cohort study used routine clinical practice data for all adult patients diagnosed with HT in the Ramathibodi Hospital, Thailand from 2010 to 2022. A multi-state model was developed based on the following: state 1-uncomplicated HT, 2-CKD, 3-CAD, 4-stroke, and 5-ACD. Transition probabilities were estimated using Kaplan-Meier method.ResultsA total of 144,149 patients were initially classified as having uncomplicated HT. The transition probabilities (95% CI) from the initial state to CKD, CAD, stroke, and ACD at 10-years were 19.6% (19.3%, 20.0%), 18.2% (17.9%, 18.6%), 7.4% (7.1%, 7.6%), and 1.7% (1.5%, 1.8%), respectively. Once in the intermediate-states of CKD, CAD, and stroke, 10-year transition probabilities to death were 7.5% (6.8%, 8.4%), 9.0% (8.2%, 9.9%), and 10.8% (9.3%, 12.5%).ConclusionsIn this 13-year cohort, CKD was observed as the most common complication, followed by CAD and stroke. Among these, stroke carried the highest risk of ACD, followed by CAD and CKD. These findings provide improved understanding of disease progression to guide appropriate prevention measures. Further investigations of prognostic factors and treatment effectiveness are warranted.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Macitentan in Pulmonary Hypertension (PH) Due to Chronic Lung Disease: Real-World Evidence from OPUS/OrPHeUS
    Sahay, S.
    Channick, R.
    Chin, K.
    McLaughlin, V.
    Agron, P.
    Ong, R.
    Wetherill, G.
    Kim, N. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S105 - S106
  • [42] Generalisability of cardiovascular RCTs to patients with chronic kidney disease in clinical practice: a comparison between RCTs and real-world data
    Colombijn, Julia Mt
    Veld, Linde Huis In't
    Kusters, Mike Pt
    de Kanter, Emilie M.
    Bots, Michiel L.
    Hooft, Lotty
    Verhaar, Marianne
    Vernooij, Robin Wm
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I95 - I96
  • [43] Chronic kidney disease and hepatitis C mutually advance liver and renal disease progression: real-world evidence from the United States
    Tran, Tram T.
    Sanchez, Yuri
    Hayes, Oscar A.
    Marx, Steven
    HEPATOLOGY, 2017, 66 : 467A - 467A
  • [44] Predicting hospitalization from real-world measures in patients with chronic kidney disease: A proof-of-principle study
    Lyden, Kate
    Abraham, Nikita
    Boucher, Robert
    Wei, Guo
    Gonce, Victoria
    Carle, Judy
    Hartsell, Sydney E.
    Christensen, Jesse
    Beddhu, Srinivasan
    DIGITAL HEALTH, 2023, 9
  • [45] Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease
    Ogawa, Eiichi
    Furusyo, Norihiro
    Azuma, Koichi
    Nakamuta, Makoto
    Nomura, Hideyuki
    Dohmen, Kazufumi
    Satoh, Takeaki
    Kawano, Akira
    Koyanagi, Toshimasa
    Ooho, Aritsune
    Takahashi, Kazuhiro
    Kato, Masaki
    Shimoda, Shinji
    Kajiwara, Eiji
    Hayashi, Jun
    ANTIVIRAL RESEARCH, 2018, 159 : 143 - 152
  • [46] Risk Factors for Coronary Artery Calcium Among Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort Study)
    He, Jiang
    Reilly, Muredach
    Yang, Wei
    Chen, Jing
    Go, Alan S.
    Lash, James P.
    Rahman, Mahboob
    DeFilippi, Chris
    Gadegbeku, Crystal
    Kanthety, Radhika
    Tao, Kaixiang
    Hamm, L. Lee
    Ojo, Akinlolu
    Townsend, Ray
    Budoff, Matthew
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12): : 1735 - 1741
  • [47] Elbasvir/Grazoprevir effectiveness in patients with Chronic Hepatitis C and Chronic Kidney Disease: real-world experience from the TRIO Network
    Younossi, Z.
    Bacon, B.
    Curry, M.
    Dieterich, D.
    Flamm, S.
    Kowdley, K.
    Milligan, S.
    Nwankwo, C.
    Tsai, N.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S748 - S749
  • [48] The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study
    Timna Agur
    Tali Steinmetz
    Shira Goldman
    Boris Zingerman
    Dana Bielopolski
    Eviatar Nesher
    Ittai Fattal
    Eshcar Meisel
    Benaya Rozen-Zvi
    Cardiovascular Diabetology, 24 (1)
  • [49] Effects of ACE inhibitor/ARB therapy and long COVID on kidney disease: a retrospective cohort study using real-world data
    Zhang, Yue
    Ba, Djibril M.
    Risher, Kathryn
    Liao, Duanping
    Parent, Leslie J.
    Ghahramani, Nasrollah
    Chinchilli, Vernon M.
    CLINICAL KIDNEY JOURNAL, 2024, 17 (07)
  • [50] Lower risk of ischemic stroke among patients with chronic kidney disease using chinese herbal medicine as add-on therapy: A real-world nationwide cohort study
    Shen, Hsuan-Shu
    Hsu, Chung-Yi
    Yip, Hei-Tung
    Lin, I-Hsin
    FRONTIERS IN PHARMACOLOGY, 2022, 13